Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?
- 31 December 1997
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 30 (7), 1589-1597
- https://doi.org/10.1016/s0735-1097(97)00361-6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)American Heart Journal, 1997
- Effects of mechano-electrical feedback: potential arrhythmogenic influence in patients with congestive heart failureCardiovascular Research, 1996
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Nonischemic sudden tachyarrhythmic death in atherosclerotic heart disease.Circulation, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Arrhythmias and mortality in congestive heart failureThe American Journal of Cardiology, 1990
- Predictors of total mortality and sudden death in mild to moderate heart failureJournal of the American College of Cardiology, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activityJournal of the American College of Cardiology, 1983
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983